Company Website
http://www.xenacareholdings.com/
Summary
XenaCare Holdings, Inc. engages in the design, development, marketing, and sale of non-prescription pharmaceuticals (NPPs) and personal lubrication gels. It operates in two divisions, XenaCare Clinical and XenaCare Performance. The XenaCare Clinical division provides XenaCare SOC, a turn-key system for the education, sale, and distribution of NPPs and services at physicians' healthcare offices; and the development, formulation, and brand building of a line of NPPs for the replenishment of nutrients. The XenaCare Performance division involves in the development and formulation of a line of NPPs, such as gels and creams for the personal performance market under the Touch n' Tingle' (TNT) brand; and the development and formulation of a line of NPPs for the energy/lifestyle performance market. XenaCare SOC operates 22 physician offices located in New York and Florida. Its NPPs include XenaCor, XenaTri, and XenaZymePlus, which are distributed through the company's site of care program. The company's TNT gels are used to support the flow and absorption for pleasurable intimacy use without unwanted side effects. It is also developing formulations for the lifestyle performance market, which consists of a sports line for athletes and for the over 50 generation. In addition, it offers body replenishment products to patients treated with prescription drugs for high blood pressure, heart disease, diabetes, ulcers, depression, infection, arthritis, aids, and weight loss. XenaCare Holdings markets its products through the Internet, pharmacies, and doctors' offices. The company was founded in 2001 and is based in Deerfield Beach, Florida.
Recent Activity
SunPill® has been accepted by three major retailers for a summer launch. Starting with Walgreen’s, the SunPill® will be featured in the sun care aisle of all their 6,500 stores nationwide. Rite-Aide, with a little over 5,000 stores, will feature the SunPill in a special end-cap display that will maintain prominent positioning for the next 14-months; 7-11 will also carry the SunPill® product in a special 6-pack blister display especially designed for the convenience store market in their approximately 7,000 stores nationwide.
The SunPill® is a dietary supplement that helps the skin protect itself from the harmful rays of the sun. It contains scientifically researched ingredients. The SunPill® is a proprietary combination of ingredients with powerful antioxidant properties that help the body’s own natural defense when it comes to exposure to the sun.
Virtually all sun care category managers at major retailers that we have contacted are very enthusiastic about the SunPill® and we believe that it will be the next great product for the summer of 08 and beyond. One major retail buyer who came up through the ranks as a pharmacist stated, “The beauty of the SunPill® is that it relies on the fact that it doesn’t cannibalize the section. This is a whole new way of addressing over exposure to the sun without taking away our topical sun care sales.”
After obtaining the name and concept for SunPill®, XenaCare Holdings re-developed and re-worked the SunPill® to be a major retail item. XenaCare has dedicated much of the past 6-months in the introduction of the SunPill® to the retail world. With a special commitment to consumer education, XenaCare has developed a 60-second direct response TV commercial along with a 30-second commercial that is being tagged with various retailers’ names.
0 comments:
Post a Comment